Press release from Companies: Kallelse till extra bolagsstämma i Hamlet Pharma AB (publ)

Press release from Companies: FDA Clearance of IND Application for Alpha1H for the treatment of non-muscle invasive bladder cancer

Press release from Companies: FDA Clearance of IND Application for Alpha1H for the treatment of non-muscle invasive bladder cancer

Press release from Companies: Petter Segelman Lindqvist appointed new CEO of Hamlet Pharma

Press release from Companies: Hamlet Pharma secures long-term Alpha1 peptide production in an agreement with Polypeptide Group

Press release from Companies: Hamlet Pharma soon to be Hamlet BioPharma presents at Aktiespararnas Capital Market Day on June 12 in Stockholm at 13.30 CET

Press release from Companies: Teckningsoptioner av serie TO 4 B tecknades till cirka 38% procent och Hamlet Pharma AB (publ) tillförs cirka 3,5 MSEK

Press release from Companies: Hamlet Pharma secures a new Alpha1H production batch for continued clinical trials

Press release from Companies: Sista dag i utnyttjandeperioden för teckningsoptioner av serie TO 4 B i Hamlet Pharma AB (publ) är imorgon, den 31 maj 2023

Reports: Hamlet Pharma AB (publ): Q3 Interim Report January 2023 – March 2023

Market Notices: Market Notice 111/23 – Last day of trading in Hamlet Pharma AB´s subscription option HAMLET TO 4 B

Press release from Companies: Introducing Hamlet BioPharma to investors